Profile - To The Moon

Yihuei

Posts · 2Posts · 2
Following · 0Following · 0
Followers · 0Followers · 0

- YihueiYihuei
  ·2021-06-09
  Wow
  5 High-Octane Growth Stocks With 54% to 94% Upside, According to Wall Street
  If analysts are correct, this assortment of rapidly growing companies could deliver big-time returns
  5 High-Octane Growth Stocks With 54% to 94% Upside, According to Wall Street
  122 Comment
  1
  Share
  Report
- YihueiYihuei
  ·2021-06-09
  ??
  2 Potentially Explosive Stocks to Buy in June
  If you're willing to take on risk, owning stock in these companies could make you rich.
  2 Potentially Explosive Stocks to Buy in June
  151 Comment
  Like
  Share
  Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3571054604223316","uuid":"3571054604223316","gmtCreate":1608046879088,"gmtModify":1665154844523,"name":"Yihuei","pinyin":"yihuei","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/395b96b6f24f3e3f4473e147ef092e01","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":1,"tweetSize":2,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.09.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.14","exceedPercentage":"60.40%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":180964385,"gmtCreate":1623169964447,"gmtModify":1704197674471,"author":{"id":"3571054604223316","authorId":"3571054604223316","name":"Yihuei","avatar":"https://community-static.tradeup.com/news/395b96b6f24f3e3f4473e147ef092e01","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571054604223316","authorIdStr":"3571054604223316"},"themes":[],"htmlText":"Wow&nbsp;","listText":"Wow&nbsp;","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/180964385","repostId":"1166056944","repostType":4,"repost":{"id":"1166056944","pubTimestamp":1623160615,"share":"https://ttm.financial/m/news/1166056944?lang=&edition=fundamental","pubTime":"2021-06-08 21:56","market":"us","language":"en","title":"5 High-Octane Growth Stocks With 54% to 94% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1166056944","media":"Motley Fool","summary":"If analysts are correct, this assortment of rapidly growing companies could deliver big-time returns","content":"<blockquote><b>If analysts are correct, this assortment of rapidly growing companies could deliver big-time returns over the next year.</b></blockquote><p>For the past 12 years, growth stocks have been the key to sending the broader market higher. Even though value stocks have been the better performer of the two categories over the very long-term, historically low lending rates and trillions of dollars being pumped into the U.S. economy have created a perfect storm for growth stocks to thrive.</p><p>Yet according to Wall Street's one-year consensus price targets, somegrowth stocksaren't anywhere near realizing their full potential. If analysts' consensus price targets prove accurate, the following five high-octane growth stocks offer upside ranging from 54% to 94% over the next year.</p><p><b>Vaxart: Implied upside of 94%</b></p><p>The supercharged growth stock on this list with thegreatest implied upsideover the coming 12 months is clinical-stagebiotech stock<b>Vaxart</b>(NASDAQ:VXRT). If you're wondering why I've included a clinical-stage drug developer, it's because all of the analysts covering it are forecasting recurring sales for the company, beginning in 2022. If Wall Street's estimates are correct, Vaxart's stock could nearly double from where it closed this past week.</p><p>What makes Vaxart such a unique drug developer is its approach to developing treatments. Specifically, it develops oral recombinant vaccines, rather than vaccines administered by injection. It should be a lot easier to dispense and administer pills than injections, which could resolve factors like shot hesitancy and vaccine access.</p><p>Even though it has multiple treatments in the works, most of the buzz surrounding Vaxart has to do with its work in the lab on VXA-CoV2-1, an experimental oral tablet to treat the coronavirus disease 2019 (COVID-19). Data from a phase 1 study in February showed VXA-CoV2-1 met all of its primary and secondary safety and immunogenicity endpoints. The data also signaled that Vaxart's oral treatment may be effective against COVID-19 variants.</p><p>Though it's probablya bit too earlyto get overly excited about Vaxart, it's a name worth closely monitoring.</p><p><b>Trulieve Cannabis: Implied upside of 88%</b></p><p>It's no secret that cannabis is set to be one of North America's fastest-growing industries this decade. But amongmarijuana stocks, U.S. multistate operator (MSO)<b>Trulieve Cannabis</b>(OTC:TCNNF)offers some of the most robust upside. If Wall Street's consensus price target of a little over $72 is correct, Trulieve could gallop higher by 88% over the coming year.</p><p>There are a lot of unique growth strategies among MSOs, but none hasproved more successful than Trulieve's blueprint. At the moment, Trulieve has 88 operational dispensaries. But here's the kicker: 82 of them are located in medical marijuana-legal Florida. By focusing its efforts on a single big-dollar state, Trulieve has been able to saturate the market, effectively build up its brand, and keep its marketing costs down. The company has been profitable for 13 consecutive quarters, and as of the end of 2020 controlled 53% of the Sunshine State's dried flower market and 49% of its high-margin cannabinoid oils market.</p><p>Equally intriguing is Trulieve's recently announced all-stock deal to acquire MSO<b>Harvest Health &amp; Recreation</b>(OTC:HRVSF)for $2.1 billion. Harvest has a focus on five states, one of which happens to be Florida. Aside from solidifying an even bigger presence in the Sunshine State, Trulieve will gain access to Harvest's state-leading 15 dispensaries in Arizona. The Grand Canyon State legalized recreational weed in November. There's a good chance Trulieve can use Harvest's infrastructure to duplicate its success in Arizona.</p><p><b>Magnite: Implied upside of 59%</b></p><p>Another high-octane growth stock with significant upside potential, according to Wall Street, is sell-side advertising technology platform<b>Magnite</b>(NASDAQ:MGNI). If analysts are correct about Magnite hitting nearly $46 a share in 12 months, it would represent upside potential of 59%.</p><p>Magnite finds itself at the center of a double-digit growth trend that should last for a long time to come. As consumers cut the cord to traditional cable and shift to other forms of entertainment and content consumption, businesseswill be more likely to shift their advertising dollarsonline, to apps, and to streaming/connected TV (CTV). Although mobile platforms accounted for almost half of Magnite's revenue last year, it's CTV that looks to be the most intriguing long-term growth driver.</p><p>One of thebiggest boostsfor Magnite should come from its recently closed cash-and-stock acquisition of SpotX. SpotX generated $31.2 million in sales (less traffic acquisition costs) in the first quarter, with $19.7 million of this net revenue attributable to CTV. That was up 70% from the prior-year period. The now-combined company has sell-side ad platform exposure to the likes of<b>fuboTV</b>,<b>Roku</b>,<b>Disney</b>, and WarnerMedia, to name a few leading platforms.</p><p>With Magnite profitable on a recurring basis and fully capable of sustainable double-digit growth, a 59% 12-month return isn't out of the question.</p><p><b>Teladoc Health: Implied upside of 56%</b></p><p>Transformativehealthcare stock<b>Teladoc Health</b>(NYSE:TDOC)is also expected to offer abundant upside potential. Based on Wall Street's consensus price target of around $229, Teladoc could rise by a cool 56% over the next 12 months.</p><p>A lot of folks view Teladoc asone of the biggest winners during the COVID-19 pandemic. With doctors wanting to keep high-risk people and infected patients out of their offices, many turned to virtual visits. Teladoc ultimately handled 10.59 million telehealth visits last year, up from 4.14 million in 2019. But these folks are probably overlooking that Teladoc grew sales by an annual average of 74% in the six years leading up to the pandemic.</p><p>What makes telemedicine such a winning trend is that itoffers advantages up and down the treatment chain. Telehealth allows patients to stay home for consultations, and it's a tool physicians can use to keep closer tabs on their chronically ill patients. This ease of oversight could result in improved patient outcomes. It also doesn't hurt that virtual visits are billed at a lower rate than office visits.</p><p>Following its acquisition of leading applied health signals company Livongo Health in the fourth quarter, Teladoc has all the tools needed to provide next-level personalized care. In other words, this price target looks very realistic over the next year.</p><p>Plug Power: Implied upside of 54%</p><p>Finally, hydrogen fuel-cell solutions company<b>Plug Power</b>(NASDAQ:PLUG)is a (pardon the irony) high-octane growth stock with ample upside. If analysts are correct about its price target of almost $47 in a year, Plug could deliver a 54% return to its shareholders.</p><p>The big buzz with Plug Power is the push by developed countries, including the U.S., to renewable sources of energy. President Biden has proposed a massive infrastructure bill tailored to renewable energy projects, which signals the federal government's willingness to invest in clean-energy solutions.</p><p>Since the year began, Plug Power landed two major joint venture partners. South Korea's SK Group took a 10% equity stake in Plug and will work with the company to develop hydrogen fuel-cell solutions for vehicles and refilling stations. Meanwhile, French auto company<b>Renault</b>formed a joint venture with Plug to tackle Europe's light commercial vehicle market. Following these joint venture announcements, the companyintroduced a gross billings target of $1.7 billion by 2024, which would almost quadruple its forecasted sales for 2021.</p><p>Whether it'll be smooth sailingremains to be seen. The company recently restated years' worth of its income statements, and history hasn't always been kind to the introduction of new automotive technology.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 High-Octane Growth Stocks With 54% to 94% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 High-Octane Growth Stocks With 54% to 94% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 21:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/08/5-high-octane-growth-stocks-with-54-to-94-upside/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If analysts are correct, this assortment of rapidly growing companies could deliver big-time returns over the next year.For the past 12 years, growth stocks have been the key to sending the broader ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/08/5-high-octane-growth-stocks-with-54-to-94-upside/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VXRT":"Vaxart, Inc","TCNNF":"Trulieve Cannabis Corporation","MGNI":"Magnite, Inc.","PLUG":"普拉格能源","TDOC":"Teladoc Health Inc."},"source_url":"https://www.fool.com/investing/2021/06/08/5-high-octane-growth-stocks-with-54-to-94-upside/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166056944","content_text":"If analysts are correct, this assortment of rapidly growing companies could deliver big-time returns over the next year.For the past 12 years, growth stocks have been the key to sending the broader market higher. Even though value stocks have been the better performer of the two categories over the very long-term, historically low lending rates and trillions of dollars being pumped into the U.S. economy have created a perfect storm for growth stocks to thrive.Yet according to Wall Street's one-year consensus price targets, somegrowth stocksaren't anywhere near realizing their full potential. If analysts' consensus price targets prove accurate, the following five high-octane growth stocks offer upside ranging from 54% to 94% over the next year.Vaxart: Implied upside of 94%The supercharged growth stock on this list with thegreatest implied upsideover the coming 12 months is clinical-stagebiotech stockVaxart(NASDAQ:VXRT). If you're wondering why I've included a clinical-stage drug developer, it's because all of the analysts covering it are forecasting recurring sales for the company, beginning in 2022. If Wall Street's estimates are correct, Vaxart's stock could nearly double from where it closed this past week.What makes Vaxart such a unique drug developer is its approach to developing treatments. Specifically, it develops oral recombinant vaccines, rather than vaccines administered by injection. It should be a lot easier to dispense and administer pills than injections, which could resolve factors like shot hesitancy and vaccine access.Even though it has multiple treatments in the works, most of the buzz surrounding Vaxart has to do with its work in the lab on VXA-CoV2-1, an experimental oral tablet to treat the coronavirus disease 2019 (COVID-19). Data from a phase 1 study in February showed VXA-CoV2-1 met all of its primary and secondary safety and immunogenicity endpoints. The data also signaled that Vaxart's oral treatment may be effective against COVID-19 variants.Though it's probablya bit too earlyto get overly excited about Vaxart, it's a name worth closely monitoring.Trulieve Cannabis: Implied upside of 88%It's no secret that cannabis is set to be one of North America's fastest-growing industries this decade. But amongmarijuana stocks, U.S. multistate operator (MSO)Trulieve Cannabis(OTC:TCNNF)offers some of the most robust upside. If Wall Street's consensus price target of a little over $72 is correct, Trulieve could gallop higher by 88% over the coming year.There are a lot of unique growth strategies among MSOs, but none hasproved more successful than Trulieve's blueprint. At the moment, Trulieve has 88 operational dispensaries. But here's the kicker: 82 of them are located in medical marijuana-legal Florida. By focusing its efforts on a single big-dollar state, Trulieve has been able to saturate the market, effectively build up its brand, and keep its marketing costs down. The company has been profitable for 13 consecutive quarters, and as of the end of 2020 controlled 53% of the Sunshine State's dried flower market and 49% of its high-margin cannabinoid oils market.Equally intriguing is Trulieve's recently announced all-stock deal to acquire MSOHarvest Health & Recreation(OTC:HRVSF)for $2.1 billion. Harvest has a focus on five states, one of which happens to be Florida. Aside from solidifying an even bigger presence in the Sunshine State, Trulieve will gain access to Harvest's state-leading 15 dispensaries in Arizona. The Grand Canyon State legalized recreational weed in November. There's a good chance Trulieve can use Harvest's infrastructure to duplicate its success in Arizona.Magnite: Implied upside of 59%Another high-octane growth stock with significant upside potential, according to Wall Street, is sell-side advertising technology platformMagnite(NASDAQ:MGNI). If analysts are correct about Magnite hitting nearly $46 a share in 12 months, it would represent upside potential of 59%.Magnite finds itself at the center of a double-digit growth trend that should last for a long time to come. As consumers cut the cord to traditional cable and shift to other forms of entertainment and content consumption, businesseswill be more likely to shift their advertising dollarsonline, to apps, and to streaming/connected TV (CTV). Although mobile platforms accounted for almost half of Magnite's revenue last year, it's CTV that looks to be the most intriguing long-term growth driver.One of thebiggest boostsfor Magnite should come from its recently closed cash-and-stock acquisition of SpotX. SpotX generated $31.2 million in sales (less traffic acquisition costs) in the first quarter, with $19.7 million of this net revenue attributable to CTV. That was up 70% from the prior-year period. The now-combined company has sell-side ad platform exposure to the likes offuboTV,Roku,Disney, and WarnerMedia, to name a few leading platforms.With Magnite profitable on a recurring basis and fully capable of sustainable double-digit growth, a 59% 12-month return isn't out of the question.Teladoc Health: Implied upside of 56%Transformativehealthcare stockTeladoc Health(NYSE:TDOC)is also expected to offer abundant upside potential. Based on Wall Street's consensus price target of around $229, Teladoc could rise by a cool 56% over the next 12 months.A lot of folks view Teladoc asone of the biggest winners during the COVID-19 pandemic. With doctors wanting to keep high-risk people and infected patients out of their offices, many turned to virtual visits. Teladoc ultimately handled 10.59 million telehealth visits last year, up from 4.14 million in 2019. But these folks are probably overlooking that Teladoc grew sales by an annual average of 74% in the six years leading up to the pandemic.What makes telemedicine such a winning trend is that itoffers advantages up and down the treatment chain. Telehealth allows patients to stay home for consultations, and it's a tool physicians can use to keep closer tabs on their chronically ill patients. This ease of oversight could result in improved patient outcomes. It also doesn't hurt that virtual visits are billed at a lower rate than office visits.Following its acquisition of leading applied health signals company Livongo Health in the fourth quarter, Teladoc has all the tools needed to provide next-level personalized care. In other words, this price target looks very realistic over the next year.Plug Power: Implied upside of 54%Finally, hydrogen fuel-cell solutions companyPlug Power(NASDAQ:PLUG)is a (pardon the irony) high-octane growth stock with ample upside. If analysts are correct about its price target of almost $47 in a year, Plug could deliver a 54% return to its shareholders.The big buzz with Plug Power is the push by developed countries, including the U.S., to renewable sources of energy. President Biden has proposed a massive infrastructure bill tailored to renewable energy projects, which signals the federal government's willingness to invest in clean-energy solutions.Since the year began, Plug Power landed two major joint venture partners. South Korea's SK Group took a 10% equity stake in Plug and will work with the company to develop hydrogen fuel-cell solutions for vehicles and refilling stations. Meanwhile, French auto companyRenaultformed a joint venture with Plug to tackle Europe's light commercial vehicle market. Following these joint venture announcements, the companyintroduced a gross billings target of $1.7 billion by 2024, which would almost quadruple its forecasted sales for 2021.Whether it'll be smooth sailingremains to be seen. The company recently restated years' worth of its income statements, and history hasn't always been kind to the introduction of new automotive technology.","news_type":1},"isVote":1,"tweetType":1,"viewCount":122,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180965398,"gmtCreate":1623169860414,"gmtModify":1704197673177,"author":{"id":"3571054604223316","authorId":"3571054604223316","name":"Yihuei","avatar":"https://community-static.tradeup.com/news/395b96b6f24f3e3f4473e147ef092e01","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571054604223316","authorIdStr":"3571054604223316"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/180965398","repostId":"2141264328","repostType":4,"repost":{"id":"2141264328","pubTimestamp":1623162620,"share":"https://ttm.financial/m/news/2141264328?lang=&edition=fundamental","pubTime":"2021-06-08 22:30","market":"us","language":"en","title":"2 Potentially Explosive Stocks to Buy in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2141264328","media":"Motley Fool","summary":"If you're willing to take on risk, owning stock in these companies could make you rich.","content":"<p>Owning just a couple of stocks that post explosive gains can be a life-changing experience for your finances. Take <b>Amazon</b> and <b>Netflix</b>, for example. If you invested in either of these companies early in their publicly traded histories and held on to your shares, you would have enjoyed incredible gains. However, investors didn't even have to get in super early to enjoy life-changing returns with these companies.</p>\n<p>E-commerce and streaming video were already fairly well established a decade ago, but many investors correctly saw that these industries still had huge room for growth. If you made a $10,000 investment in Netflix stock 10 years ago, your holdings would now be worth roughly $132,000. That same $10,000 investment in Amazon stock would be worth about $173,000 at today's prices.</p>\n<p>Growth-dependent tech stocks are prone to volatile pricing swings, but taking a buy-and-hold approach to quality companies in the space can transform your portfolio's performance. Read on for a look at two companies that could deliver huge returns for risk-tolerant investors.</p>\n<p><img src=\"https://static.tigerbbs.com/d5f5f38a6fbdad8558b62e795c8b4d3e\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p>1. Appian</p>\n<p><b>Appian</b> (NASDAQ:APPN) provides a software development platform that allows users to quickly build and deploy applications. The company's app-building service allows users to \"drag and drop\" different features and processes into projects, creating a streamlined and accessible approach to software development. This setup can help companies complete projects faster and it allows even relatively inexperienced developers to create applications that improve workflow efficiency.</p>\n<p>Software will only become increasingly essential to business success, and Appian should have plenty of opportunities to attract new clients and boost spending on its platform. However, you probably wouldn't get that impression if you looked at its stock performance in recent months.</p>\n<p><img src=\"https://static.tigerbbs.com/22e3f29f0a174d8c0f0da174104a13d5\" tg-width=\"720\" tg-height=\"419\" referrerpolicy=\"no-referrer\"></p>\n<p>APPN data by YCharts</p>\n<p>After an impressive run, the stock price has plummeted roughly 65% from the record high it hit earlier this year. What's at the root of the crushing sell-off? For <a href=\"https://laohu8.com/S/AONE\">one</a>, tech stocks have felt the squeeze as investors have rotated into economic reopening plays and value-oriented names. Slowing growth at Appian has also weighed on the company's valuation.</p>\n<p>Revenue climbed just 13% year over year in the quarter to reach $88.9 million, although that doesn't tell the whole story because the company is still in the process of pivoting to a more subscription-heavy business model. Overall subscription revenue rose 26% compared to the prior-year period to reach $63.8 million,&nbsp;which is still significantly below the 31% annual growth rate the segment posted last year, but the deceleration isn't hugely concerning at this point.</p>\n<p>Appian has a market capitalization of roughly $6.4 billion and is valued at approximately 18 times this year's expected sales. That's still a highly growth-dependent valuation, but demand for accessible software development and process automation services could increase dramatically over the next decade and beyond, and the business has a long runway for expansion. For patient investors, Appian stock could go on to be a big winner.</p>\n<h3>2. Baozun</h3>\n<p><b>Baozun</b> (NASDAQ:BZUN) is a China-based e-commerce services specialist that's sometimes compared to <b>Shopify</b> because both companies provide website-creation tools that help businesses launch and run online retail stores. With Shopify's stock up roughly 3,920% over the last five years, it's an eye-catching comparison, but there are some key distinctions investors should be aware of.</p>\n<p>Baozun provides website creation tools, customer management, advertising and marketing, and warehousing and order-fulfillment services, and its core customer base consists of large Western companies that are aiming to benefit from the massive and fast-growing Chinese e-commerce market. Its platform also allows companies to integrate their stores into&nbsp;many of China's biggest e-commerce hubs, including <b>Alibaba</b>'s Tmall, <b>JD.com</b>, <b>Tencent</b>'s WeChat, and ByteDance's Douyin (the Chinese version of TikTok).</p>\n<p>Baozun has a leading position in its corner of the e-commerce market, but it's fair to say that the business has given investors reason to be cautious over the last few years. Despite shifting some focus away from warehousing and order fulfillment services in favor of prioritizing its web platform, margins have grown at slower than expected rates -- and actually contracted in some quarters.</p>\n<p>Sales and earnings growth have been uneven despite signs of progress on some important fronts, and the company has also raised funding for growth initiatives through substantial new share offerings that have diluted the stock.&nbsp;Factor in geopolitical concerns stemming from tensions between the U.S. and China, and it's not hard to see why Baozun's stock performance has lagged far behind Shopify's.</p>\n<p>Despite surging roughly 417% over the last five years, Baozun's stock price is actually down about 45% over the last three-year period.&nbsp;However, it looks like margins are starting to climb again, and the business still has big growth potential as it caters to Western brands and moves to expand adoption of its services among large and small domestic businesses.</p>\n<p>With the company valued at roughly $2.7 billion and its stock trading at approximately 26.5 times this year's expected earnings, Baozun offers investors an attractive risk-reward dynamic and could wind up crushing expectations.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Potentially Explosive Stocks to Buy in June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Potentially Explosive Stocks to Buy in June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/08/2-potentially-explosive-stocks-to-buy-in-june/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Owning just a couple of stocks that post explosive gains can be a life-changing experience for your finances. Take Amazon and Netflix, for example. If you invested in either of these companies early ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/08/2-potentially-explosive-stocks-to-buy-in-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"APPN":"Appian Corp","BZUN":"宝尊电商"},"source_url":"https://www.fool.com/investing/2021/06/08/2-potentially-explosive-stocks-to-buy-in-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2141264328","content_text":"Owning just a couple of stocks that post explosive gains can be a life-changing experience for your finances. Take Amazon and Netflix, for example. If you invested in either of these companies early in their publicly traded histories and held on to your shares, you would have enjoyed incredible gains. However, investors didn't even have to get in super early to enjoy life-changing returns with these companies.\nE-commerce and streaming video were already fairly well established a decade ago, but many investors correctly saw that these industries still had huge room for growth. If you made a $10,000 investment in Netflix stock 10 years ago, your holdings would now be worth roughly $132,000. That same $10,000 investment in Amazon stock would be worth about $173,000 at today's prices.\nGrowth-dependent tech stocks are prone to volatile pricing swings, but taking a buy-and-hold approach to quality companies in the space can transform your portfolio's performance. Read on for a look at two companies that could deliver huge returns for risk-tolerant investors.\n\nImage source: Getty Images.\n1. Appian\nAppian (NASDAQ:APPN) provides a software development platform that allows users to quickly build and deploy applications. The company's app-building service allows users to \"drag and drop\" different features and processes into projects, creating a streamlined and accessible approach to software development. This setup can help companies complete projects faster and it allows even relatively inexperienced developers to create applications that improve workflow efficiency.\nSoftware will only become increasingly essential to business success, and Appian should have plenty of opportunities to attract new clients and boost spending on its platform. However, you probably wouldn't get that impression if you looked at its stock performance in recent months.\n\nAPPN data by YCharts\nAfter an impressive run, the stock price has plummeted roughly 65% from the record high it hit earlier this year. What's at the root of the crushing sell-off? For one, tech stocks have felt the squeeze as investors have rotated into economic reopening plays and value-oriented names. Slowing growth at Appian has also weighed on the company's valuation.\nRevenue climbed just 13% year over year in the quarter to reach $88.9 million, although that doesn't tell the whole story because the company is still in the process of pivoting to a more subscription-heavy business model. Overall subscription revenue rose 26% compared to the prior-year period to reach $63.8 million, which is still significantly below the 31% annual growth rate the segment posted last year, but the deceleration isn't hugely concerning at this point.\nAppian has a market capitalization of roughly $6.4 billion and is valued at approximately 18 times this year's expected sales. That's still a highly growth-dependent valuation, but demand for accessible software development and process automation services could increase dramatically over the next decade and beyond, and the business has a long runway for expansion. For patient investors, Appian stock could go on to be a big winner.\n2. Baozun\nBaozun (NASDAQ:BZUN) is a China-based e-commerce services specialist that's sometimes compared to Shopify because both companies provide website-creation tools that help businesses launch and run online retail stores. With Shopify's stock up roughly 3,920% over the last five years, it's an eye-catching comparison, but there are some key distinctions investors should be aware of.\nBaozun provides website creation tools, customer management, advertising and marketing, and warehousing and order-fulfillment services, and its core customer base consists of large Western companies that are aiming to benefit from the massive and fast-growing Chinese e-commerce market. Its platform also allows companies to integrate their stores into many of China's biggest e-commerce hubs, including Alibaba's Tmall, JD.com, Tencent's WeChat, and ByteDance's Douyin (the Chinese version of TikTok).\nBaozun has a leading position in its corner of the e-commerce market, but it's fair to say that the business has given investors reason to be cautious over the last few years. Despite shifting some focus away from warehousing and order fulfillment services in favor of prioritizing its web platform, margins have grown at slower than expected rates -- and actually contracted in some quarters.\nSales and earnings growth have been uneven despite signs of progress on some important fronts, and the company has also raised funding for growth initiatives through substantial new share offerings that have diluted the stock. Factor in geopolitical concerns stemming from tensions between the U.S. and China, and it's not hard to see why Baozun's stock performance has lagged far behind Shopify's.\nDespite surging roughly 417% over the last five years, Baozun's stock price is actually down about 45% over the last three-year period. However, it looks like margins are starting to climb again, and the business still has big growth potential as it caters to Western brands and moves to expand adoption of its services among large and small domestic businesses.\nWith the company valued at roughly $2.7 billion and its stock trading at approximately 26.5 times this year's expected earnings, Baozun offers investors an attractive risk-reward dynamic and could wind up crushing expectations.","news_type":1},"isVote":1,"tweetType":1,"viewCount":151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}